Palasyo, tiniyak na magkakaroon ng resulta ng imbestigasyon ng DOJ sa korupsyon sa PhilHealth

By Chona Yu August 09, 2020 - 04:53 PM

Tiniyak ng Palasyo ng Malacanang na magkakaroon na ng resulta ang imbestigasyon ng Department of Justice (DOJ) sa kontrobersiya sa PhilHealth sa loob lamang ng 30 araw.

Ayon kay Presidential Spokesman Harry Roque, pinagsusumite kasi ang binuong task force ng DOJ ng findings at recommendation sa loob ng 30 araw.

“There is no turning back as we expect the Task Force to submit its findings and recommendations to the Office of the President within thirty (30) days after its constitition as directed by the Chief Executive,” pahayag ni Roque.

Kasabay nito, ipinauubaya na ng Palasyo sa Senado ang pagpapasya sa hindi pagsipot nina PhilHealth President Ricardo Morales at PhilHealth Executive Vice President Arnel de Jesus sa pagdinig ng Senado sa August 11.

Hindi sisipot si Morales dahil sa kanyang lymphoma habang si de Kesus naman ay may medical emergency.

“As far as the Executive is concerned, the Task Force organized by the Department of Justice, upon the instruction of President Rodrigo Roa Duterte, will proceed in its mandate to investigate on the various allegations of corruption in PhilHealth, including the audit of PhilHealth finances and the conduct of lifestyle checks on its officials and employees, and if warranted, to recommend the preventive suspension on any official to ensure that the probe of the Task Force would be unhampered,” pahayag ni Roque.

TAGS: Arnel de Jesus, DOJ investigation on PhilHealth corruption, Inquirer News, Radyo Inquirer news, Ricardo Morales, Sec. Harry Roque, senate hearing, Arnel de Jesus, DOJ investigation on PhilHealth corruption, Inquirer News, Radyo Inquirer news, Ricardo Morales, Sec. Harry Roque, senate hearing

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.